Modeling study for optimization of skin dose for partial breast irradiation using Xoft Axxent electronic brachytherapy applicator

被引:9
作者
Hepel, Jaroslaw T. [1 ,2 ]
Hiatt, Jessica R. [1 ,2 ]
Cardarelli, Gene A. [1 ,2 ]
Wazer, David E. [1 ,2 ]
机构
[1] Tufts Univ, Tufts New England Med Ctr, Dept Radiat Oncol, Boston, MA 02111 USA
[2] Brown Univ, Rhode Isl Hosp, Dept Radiat Oncol, Providence, RI 02903 USA
关键词
Breast cancer; Skin dose; Electronic brachytherapy; Xoft Axxent; Balloon brachytherapy; 20-YEAR FOLLOW-UP; RADIATION-THERAPY; CONSERVING SURGERY; PATHOLOGICAL FINDINGS; TUMOR BED; CANCER; LUMPECTOMY; RECURRENCE; MASTECTOMY; EXPERIENCE;
D O I
10.1016/j.brachy.2009.08.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: Balloon brachytherapy with the MammoSite system (Hologic Inc., Bedford, MA) is a widely used approach for accelerated partial breast irradiation. Inherent to this approach, high skin doses can occur if the balloon to skin distance is small. This has been associated with late skin toxicity, particularly telangiectasia. The Xoft Axxent electronic brachytherapy balloon applicator (Xoft, Fremont, CA) is a novel device for accelerated partial breast irradiation. It is unique in that it uses an electronic 50-kV source. This source has a pronounced anisotropy with constriction of isodose distribution at the proximal end of the catheter. This anisotropy can be considered as an advantage to optimize skin dose when the cavity to skin distance is small. In this study, we simulated various balloon-insertion orientations to optimized skin surface dose. METHODS: Breast phantoms were constructed of tissue-equivalent material. Xoft Axxent balloon catheters were inserted at a distance of 6 mm from the surface. The catheter was placed at three different catheter to surface orientations: (1) perpendicular to the surface, (2) oblique to the surface (450), and (3) parallel to the surface. Three-dimensional treatment planning was then performed using Nucletron's Plato planning system (Nucletron, Columbia, MD). Multiple dwell positions were used, and the dose was optimized to the target volume. The target volume was defined as volume from the balloon surface to 1-cm distance from the balloon surface or to the phantom surface (if less then 1 cm from the balloon surface). Target volume coverage was compared between plans using dose volume histograms. Surface doses were compared using isodose line distribution and surface point doses. Plato planned surface doses were then verified by direct measurement using Landauer Dot InLight dosimeters (Landauer, Glenwood, IL). RESULTS: Excellent target coverage was obtained for all three catheter orientations with a D(95) of >= 95. Surface dose was lowest for the perpendicular orientation with a calculated dose of 99%. The parallel orientation had the highest surface dose of 164%. The oblique orientation showed intermediate results with a surface dose of 117%. Measured surface doses were reproducible and correlated well with calculated values. CONCLUSION: Optimized Xoft Axxent balloon catheter orientation using source anisotropy and multiple dwell positions can be used to minimize excessive skin dose and yet maintain optimal tumor cavity coverage when the cavity to skin distance is small. This has the potential to decrease skin late effects and improve cosmetic outcome. Further clinical study is warranted. (C) 2010 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:81 / 85
页数:5
相关论文
共 24 条
[1]   Optimization of mammosite therapy [J].
Astrahan, MA ;
Jozsef, G ;
Streeter, OE .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (01) :220-232
[2]   Optically stimulated luminescence of aluminum oxide detectors for radiation therapy quality assurance [J].
Danzer, J. ;
Dudney, C. ;
Seibert, R. ;
Robison, B. ;
Harris, C. ;
Ramsey, C. .
MEDICAL PHYSICS, 2007, 34 (06) :2628-2629
[3]   A dosimetric comparison of MammoSite high-dose-rate brachytherapy and Xoft Axxent electronic brachytherapy [J].
Dickler, Adam ;
Kirk, Michael C. ;
Seif, Neil ;
Griem, Katherine ;
Dowlatshahi, Kambiz ;
Francescatti, Darius ;
Abrams, Ross A. .
BRACHYTHERAPY, 2007, 6 (02) :164-168
[4]   Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator [J].
Edmundson, GK ;
Vicini, FA ;
Chen, PY ;
Mitchell, C ;
Martinez, AA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (04) :1132-1139
[5]   TOLERANCE OF NORMAL TISSUE TO THERAPEUTIC IRRADIATION [J].
EMAMI, B ;
LYMAN, J ;
BROWN, A ;
COIA, L ;
GOITEIN, M ;
MUNZENRIDER, JE ;
SHANK, B ;
SOLIN, LJ ;
WESSON, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (01) :109-122
[6]   Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer [J].
Fisher, B ;
Anderson, S ;
Bryant, J ;
Margolese, RG ;
Deutsch, M ;
Fisher, ER ;
Jeong, J ;
Wolmark, N .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (16) :1233-1241
[7]  
FISHER ER, 1986, CANCER-AM CANCER SOC, V57, P1717, DOI 10.1002/1097-0142(19860501)57:9<1717::AID-CNCR2820570902>3.0.CO
[8]  
2-H
[9]  
FISHER ER, 1992, SEMIN SURG ONCOL, V8, P161
[10]   LONG-TERM OUTCOME FOLLOWING BREAST-CONSERVING SURGERY AND RADIATION-THERAPY [J].
GAGE, I ;
RECHT, A ;
GELMAN, R ;
NIXON, AJ ;
SILVER, B ;
BORNSTEIN, BA ;
HARRIS, JR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 33 (02) :245-251